Clinical Trial Update: Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma [Phase 2]

View source ↗

Summary

Phase II trial update for Ganoderma Lucidum Spore Powder as postoperative chemotherapy for osteosarcoma (Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Ganoderma lucidum spore powder

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Osteosarcoma | Phase 2 | Status: UNKNOWN